AFP and End Stage Liver Disease: The median AFP and pre-treatment HCV-RNA levels were 3.8 ng/mL and 905,000 IU/mL, respectively, and the median Child–Pugh and model for end-stage liver disease (MELD) scores were 5.0 and 7.0, respectively.